GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yixintang Pharmaceutical Group Co Ltd (SZSE:002727) » Definitions » Cyclically Adjusted Revenue per Share

Yixintang Pharmaceutical Group Co (SZSE:002727) Cyclically Adjusted Revenue per Share : ¥20.23 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Yixintang Pharmaceutical Group Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Yixintang Pharmaceutical Group Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥8.556. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥20.23 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Yixintang Pharmaceutical Group Co's average Cyclically Adjusted Revenue Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-10), Yixintang Pharmaceutical Group Co's current stock price is ¥17.95. Yixintang Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥20.23. Yixintang Pharmaceutical Group Co's Cyclically Adjusted PS Ratio of today is 0.89.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Yixintang Pharmaceutical Group Co was 2.37. The lowest was 0.89. And the median was 1.39.


Yixintang Pharmaceutical Group Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Yixintang Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yixintang Pharmaceutical Group Co Cyclically Adjusted Revenue per Share Chart

Yixintang Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 16.26 17.83 19.61

Yixintang Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.33 18.70 19.24 19.61 20.23

Competitive Comparison of Yixintang Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share

For the Pharmaceutical Retailers subindustry, Yixintang Pharmaceutical Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yixintang Pharmaceutical Group Co's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yixintang Pharmaceutical Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Yixintang Pharmaceutical Group Co's Cyclically Adjusted PS Ratio falls into.



Yixintang Pharmaceutical Group Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yixintang Pharmaceutical Group Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=8.556/115.2271*115.2271
=8.556

Current CPI (Mar. 2024) = 115.2271.

Yixintang Pharmaceutical Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.651 98.200 3.111
201409 2.232 98.900 2.600
201412 2.292 99.000 2.668
201503 2.305 99.900 2.659
201506 2.493 99.500 2.887
201509 2.663 100.500 3.053
201512 2.757 100.600 3.158
201603 2.839 102.200 3.201
201606 2.832 101.400 3.218
201609 3.041 102.400 3.422
201612 3.293 102.600 3.698
201703 3.487 103.200 3.893
201706 3.524 103.100 3.939
201709 3.752 104.100 4.153
201712 4.127 104.500 4.551
201803 3.837 105.300 4.199
201806 3.721 104.900 4.087
201809 4.100 106.600 4.432
201812 4.502 106.500 4.871
201903 4.558 107.700 4.877
201906 4.327 107.700 4.629
201909 4.560 109.800 4.785
201912 4.964 111.200 5.144
202003 5.379 112.300 5.519
202006 5.110 110.400 5.333
202009 5.654 111.700 5.833
202012 5.832 111.500 6.027
202103 5.788 112.662 5.920
202106 5.527 111.769 5.698
202109 6.414 112.215 6.586
202112 6.900 113.108 7.029
202203 6.760 114.335 6.813
202206 6.655 114.558 6.694
202209 6.826 115.339 6.819
202212 9.032 115.116 9.041
202303 7.441 115.116 7.448
202306 7.129 114.558 7.171
202309 6.959 115.339 6.952
202312 7.565 114.781 7.594
202403 8.556 115.227 8.556

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Yixintang Pharmaceutical Group Co  (SZSE:002727) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Yixintang Pharmaceutical Group Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=17.95/20.23
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Yixintang Pharmaceutical Group Co was 2.37. The lowest was 0.89. And the median was 1.39.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Yixintang Pharmaceutical Group Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Yixintang Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Yixintang Pharmaceutical Group Co (SZSE:002727) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Hongxiang Road, Economic Development Zone, Yunnan province, Kunming City, CHN, 650500
Yixintang Pharmaceutical Group Co Ltd is a China-based company engages in the operation of pharmaceutical retail chains and wholesale businesses. Its products include traditional Chinese medicine, Western medicine, and medical equipment.
Executives
Zhang Yong Directors, executives
Xiao Dong Lei Executives
Liu Qiong Director
Ruan Hong Xian Directors, executives
Guo Chun Li Director
Ruan Guo Wei Directors, executives
Li Zheng Hong Directors, executives
Zhao Biao Directors, executives
Tian Jun Directors, Directors, and Executives
Xu Ke Yi Director
Luo Yong Bin Executives
Zhou Hong Yun Directors, executives

Yixintang Pharmaceutical Group Co (SZSE:002727) Headlines

No Headlines